Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 Jan 1;165(1):140-5.
doi: 10.1084/jem.165.1.140.

Leishmania promastigotes are recognized by the macrophage receptor for advanced glycosylation endproducts

D M Mosser, H Vlassara, P J Edelson, A Cerami

Leishmania promastigotes are recognized by the macrophage receptor for advanced glycosylation endproducts

D M Mosser et al. J Exp Med. .

Abstract

In this paper we demonstrate the involvement of the macrophage receptor for advanced glycosylation endproducts (AGE) in the phagocytosis of Leishmania major promastigotes. Blocking of this receptor with the ligand, AGE-BSA, leads to a 50% decrease in phagocytosis relative to controls, and a comparable decrease in the respiratory burst. The inhibition of phagocytosis by AGE-BSA was specific to leishmania. The binding of zymosan or C3bi-RBC and the phagocytosis of IgG-RBC or latex beads was not affected by the presence of AGE-BSA. Blocking of both the AGE receptor and CR3 decreases leishmania binding by nearly 90%, and reduces the respiratory burst by 80%, indicating that the two receptors account for the bulk of L. tropica promastigote recognition and uptake by the macrophage.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5190-2 - PubMed
    1. J Immunol. 1985 Oct;135(4):2785-9 - PubMed
    1. Proc Natl Acad Sci U S A. 1984 May;81(9):2684-8 - PubMed
    1. J Exp Med. 1984 Jul 1;160(1):197-207 - PubMed
    1. J Immunol. 1981 Oct;127(4):1438-43 - PubMed